What is the current market size and future outlook for the cognitive diagnostics market?
The cognitive diagnostics market size has grown exponentially in recent years. It will grow from $5.07 $ billion in 2024 to $6.25 $ billion in 2025 at a compound annual growth rate (CAGR) of 23.1%. The growth in the historic period can be attributed to increased prevalence of cognitive disorders, advances in neuroimaging technology, growing awareness of early diagnosis, a rising geriatric population, government funding for research, expanding clinical trials, and increased demand for personalized medicine.
The cognitive diagnostics market size is expected to see exponential growth in the next few years. It will grow to $14.25 $ billion in 2029 at a compound annual growth rate (CAGR) of 22.9%. The growth in the forecast period can be attributed to growing adoption of digital health technologies, increased focus on early and preventive diagnostics, rising prevalence of neurodegenerative diseases, development of advanced biomarkers, expansion of telemedicine and remote monitoring, enhanced research and development investments, and growing healthcare expenditure. Major trends in the forecast period include integration of AI and big data analytics, expansion of digital cognitive assessment tools, increased use of wearable devices for cognitive monitoring, advances in biomarker discovery, rise in personalized and precision medicine, growth of remote and telehealth diagnostics, development of integrated care solutions, and increased collaboration between tech companies and healthcare providers.
Get Your Free Sample of The Global Cognitive Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19373&type=smp
How has the cognitive diagnostics market evolved, and what factors have shaped its growth?
The escalating incidence of neurological disorders is expected to propel the growth of the cognitive diagnostics market going forward. Neurological disorders are medical conditions that affect the brain, spinal cord, and nervous system, impairing their function and leading to symptoms such as cognitive decline, motor dysfunction, and sensory abnormalities. The rise in neurological disorders is driven by an increased prevalence of age-related conditions such as Alzheimer’s and Parkinson’s disease. Moreover, hereditary factors, along with environmental toxins, stress, unhealthy diets, and sedentary lifestyles, contribute to the increasing prevalence of neurological disorders. Cognitive diagnostics are used in neurological diseases to assess, detect, and monitor cognitive impairments, aiding in the early diagnosis and management of conditions like Alzheimer’s and Parkinson’s disease. For instance, in May 2024, according to a report by the Alzheimer’s Association, a U.S.-based nonprofit organization dedicated to Alzheimer’s care, support, and research, the number of Americans aged 65 and older diagnosed with Alzheimer’s dementia rose from 6.5 million in 2022 to an estimated 6.9 million in 2024. Therefore, the escalating incidence of neurological disorders is driving the growth of the cognitive diagnostics market.
What are the major segments of the cognitive diagnostics market?
The cognitive diagnosticsmarket covered in this report is segmented –
1) By Diagnosis: Brain Imaging Tests, Laboratory Testing, Mental Status Testing, Rapid Home Screening Tests, Neuropsychological Testing, Electroencephalogram (EEG), Cognitive Function And Behavioral Tests, Neuropsychiatric Inventory Questionnaire (NPI-Q)
2) By Indication: Alzheimer’s Disease, Attention Deficit Or Hyperactivity Disorder, Dementia, Epilepsy-Related Cognitive Dysfunction, Mild Cognitive Impairment, Parkinson’s Disease-Related Cognitive Dysfunction, Stroke-Related Cognitive Dysfunction, Traumatic Brain Injury, Other Indications
3) By End User: Hospitals, Neurology Clinics, Cognitive Behavioral Therapy Centers, Rehabilitation Centers, Academic And Research Institutes, Diagnostic Imaging Centers, Home Care Settings
Subsegments:
1) By Brain Imaging Tests: Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Computed Tomography (CT) Scans, Functional MRI (fMRI), Single-Photon Emission Computed Tomography (SPECT), Magnetoencephalography (MEG)
2) By Laboratory Testing: Blood Biomarkers for Cognitive Disorders, Genetic Testing for Cognitive Impairment, CSF (Cerebrospinal Fluid) Biomarker Tests, Hormonal and Metabolic Testing, Genetic Sequencing for Alzheimer’s Disease
3) By Mental Status Testing: Mini-Mental State Examination (MMSE), Montreal Cognitive Assessment (MoCA), Saint Louis University Mental Status (SLUMS) Exam, Cognitive Assessment Screening Tools
4) By Rapid Home Screening Tests: Self-Administered Cognitive Tests, Mobile App-Based Cognitive Screening, At-Home Memory and Mental Health Tests
5) By Neuropsychological Testing: Cognitive and Behavioral Assessment Batteries, Attention and Memory Function Tests, Executive Function and Problem-Solving Tests, Verbal and Visual Learning Tests
6) By Electroencephalogram (EEG): Resting-State EEG for Cognitive Disorders, Event-Related Potential (ERP) Testing, Quantitative EEG (QEEG) for Brain Mapping, Long-Term EEG Monitoring for Cognitive Disorders
7) By Cognitive Function and Behavioral Tests: Memory Function Tests, Attention and Concentration Tests, Language and Communication Tests, Mood and Behavior Assessments
8) By Neuropsychiatric Inventory Questionnaire (NPI-Q): NPI-Q for Dementia Screening, Behavioral and Psychological Symptoms of Dementia (BPSD) Assessment, NPI-Q for Alzheimer’s Disease and Other Cognitive Disorders, Shortened Versions of NPI-Q for Clinical Settings.
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/cognitive-diagnostics-global-market-report
Which companies dominate the cognitive diagnostics market?
Major companies operating in the cognitive diagnostics market are Cogstate Ltd., Viz.ai, Redcliffe Labs, Mind Maze, Neurocare Group AG, Pathway Genomics, Diadem srl, Cambridge Cognition Ltd., Posit Science Corporation, Anderson Diagnostics & Labs., Altoida AG, BrainScope Company Inc., Neurotrack Technologies Inc., Cognetivity Neurosciences Ltd., BrainCheck, Cyclops MedTech Pvt Ltd, Twill Inc., CN Diagnostics, Savonix Inc., Cognivue Inc., NeuroCog Trials, Pearson Clinical, Re:Cognition Health, CogniSense, The Neuropsychology Consultants
How will evolving trends contribute to the growth of the cognitive diagnostics market?
Major companies operating in the cognitive diagnostics market focus on real-time insights into cognitive health with technological advancements in diagnostic tools such as neuropsychological testing platforms, to enhance accuracy, efficiency, and comprehensiveness in cognitive assessments. Neuropsychological testing platforms are specialized digital tools designed to assess cognitive functions through standardized tests, including memory, attention, and problem-solving skills. For instance, in April 2024, BrainCheck Inc., a US-based digital health company powering positive progress in cognitive health, unveiled its comprehensive digital cognitive assessment platform at the American Academy of Neurology (AAN) Annual Meeting, showcasing its advanced tools for cognitive screening, assessment, and care planning. The platform, including Assess, Screen, and Plan, offers clinicians a modern solution to streamline cognitive health management with mobile, digital technology that ensures accuracy and ease of use. This innovation aims to enhance the efficiency and quality of care for patients and providers by offering nuanced, evidence-based recommendations and comprehensive care planning.
What are the key regional dynamics of the cognitive diagnostics market, and which region leads in market share?
North America was the largest region in the cognitive diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cognitive diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Does The Cognitive Diagnostics Market Report 2025 Offer?
The cognitive diagnostics market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Cognitive diagnostics refers to the process of assessing and evaluating an individual’s cognitive functions to diagnose and understand cognitive disorders or impairments. This field focuses on identifying issues related to memory, attention, language, problem-solving, and other cognitive abilities. It involves a variety of methods and tools to analyze cognitive performance and determine the presence of conditions such as dementia, Alzheimer’s disease, traumatic brain injury, or other cognitive impairments.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19373
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
